Rezultati pretraživanja
  1. prije 15 sati
  2. 4. velj

    Today is . Join as we strive to find new therapies for difficult-to-treat cancers. Together, we can advance medicine with precision in the pursuit of new treatment options.

  3. 3. velj
  4. 3. velj

    Congratulations to the team and our new shareholders for the start of a new chapter. We look forward to continuing to live by our brand promise to advance medicine with precision.

  5. 3. velj

    Welcome investors to . This new site provides the latest updates on and our progress as we advance medicine with precision.

  6. 29. sij

    Thank you for hosting the Annual Annapolis Day & Leadership Dinner. enjoyed speaking with General Assembly Members about delivering innovative solutions to pressing healthcare challenges.

  7. 15. sij

    Triple-Gene to highlight its investigational in Phase 1 for treatment of at TODAY January 15th at 11:30am PT in Franciscan B at the Hilton San Francisco Union Square

  8. 14. sij

    At ? Listen to Dr. Helen Sabzevari, President & CEO of , at 5pm PT in California West present on progress and 2020 look ahead OR watch live webcast here:

  9. 6. sij

    receives first regulatory designation for PRGN-3006 UltraCAR-T

  10. 2. sij

    appoints Helen Sabzevari, PhD, as new President and CEO and will change name to to reflect healthcare focus. Join us at on January 14 at 5pm PT to hear Helen's vision for the new Precigen

  11. 23. pro 2019.

    Team celebrates the holidays in our offices! from our family to yours

  12. 19. stu 2019.

    UltraCAR T cells for the treatment of AML and MDS

  13. 4. stu 2019.

    will host a conference call to provide business and pipeline updates on November 12, 2019 at 11:00 AM ET. Register to participate

  14. 17. lis 2019.

    Secretary tours ’s gene therapy manufacturing facility with President Dr. Helen Sabzevari and Precigen team members Rutul Shah and Bryan Butman

  15. 10. lis 2019.

    Thank you for an engaging panel discussion on personalized medicine and gene therapy hosted at ’s headquarters in .

  16. 8. kol 2019.

    Breaking News: Intrexon Reports Second Quarter and First Half 2019 Financial Results: -Gene -BrowningLettuce

  17. 14. lip 2019.
  18. 1. ožu 2019.

    a mention on the call by Steve as to a manufacturing facility to be built later on this year (dealing with POC CarT I believe) - must be confident on a new partnering deal b4 or soon after some early data to consider such....imo. #3 POC CAR's dosing patients soon.

  19. 28. velj 2019.

    "rapidly moving forward toward Autonomy" ~Dr. Helen Sabsevari. Maybe IPO public by year end? (Sound quite independent in decision making already) "Made much improvements on SBTS since 1st/2nd Gen SBTS with UtraCarT POC CarT" (but of course) Have to own XON 4-IPO

  20. 7. sij 2019.

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.